Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions.

Lassa fever (LF) is a potentially lethal viral haemorrhagic infection of humans caused by Lassa mammarenavirus (LASV). It is an important endemic zoonotic disease in West Africa with growing evidence for increasing frequency and sizes of outbreaks. Phylogeographic and molecular epidemiology methods have projected expansion of the Lassa fever endemic zone in the context of future global change. The Natal multimammate mouse (Mastomys natalensis) is the predominant LASV reservoir, with few studies investigating the role of other animal species. To explore host sequencing biases, all LASV nucleotide sequences and associated metadata available on GenBank (n = 2,298) were retrieved. Most data originated from Nigeria (54%), Guinea (20%) and Sierra Leone (14%). Data from non-human hosts (n = 703) were limited and only 69 sequences encompassed complete genes. We found a strong positive correlation between the number of confirmed human cases and sequences at the country level (r = 0.93 (95% Confidence Interval = 0.71 - 0.98), p < 0.001) but no correlation exists between confirmed cases and the number of available rodent sequences (r = -0.019 (95% C.I. -0.71 - 0.69), p = 0.96). Spatial modelling of sequencing effort highlighted current biases in locations of available sequences, with increased effort observed in Southern Guinea and Southern Nigeria. Phylogenetic analyses showed geographic clustering of LASV lineages, suggestive of isolated events of human-to-rodent transmission and the emergence of currently circulating strains of LASV from the year 1498 in Nigeria. Overall, the current study highlights significant geographic limitations in LASV surveillance, particularly, in non-human hosts. Further investigation of the non-human reservoir of LASV, alongside expanded surveillance, are required for precise characterisation of the emergence and dispersal of LASV. Accurate surveillance of LASV circulation in non-human hosts is vital to guide early detection and initiation of public health interventions for future Lassa fever outbreaks.

[1]  Anna R. Sjodin,et al.  Identifying the genetic basis of viral spillover using Lassa virus as a test case , 2023, Royal Society Open Science.

[2]  D. Simons Lassa fever cases suffer from severe underreporting based on reported fatalities , 2022, International Health.

[3]  C. Ihekweazu,et al.  Pathogens that Cause Illness Clinically Indistinguishable from Lassa Fever, Nigeria, 2018 , 2022, Emerging infectious diseases.

[4]  A. Anyogu,et al.  The deuce-ace of Lassa Fever, Ebola virus disease and COVID-19 simultaneous infections and epidemics in West Africa: clinical and public health implications , 2021, Tropical Medicine and Health.

[5]  Donald S. Grant,et al.  Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades , 2021, bioRxiv.

[6]  C. Ihekweazu,et al.  Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017 , 2020, The Pan African medical journal.

[7]  Dhamari Naidoo,et al.  Nigeria’s efforts to strengthen laboratory diagnostics – Why access to reliable and affordable diagnostics is key to building resilient laboratory systems , 2020, African journal of laboratory medicine.

[8]  D. Forni,et al.  Population Structure of Lassa Mammarenavirus in West Africa , 2020, Viruses.

[9]  F. I. Ibukun,et al.  Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development , 2020, Viruses.

[10]  E. Fichet-Calvet,et al.  Systematics, Ecology, and Host Switching: Attributes Affecting Emergence of the Lassa Virus in Rodents across Western Africa , 2020, Viruses.

[11]  T. Strecker,et al.  Determining Ancestry between Rodent- and Human-Derived Virus Sequences in Endemic Foci: Towards a More Integral Molecular Epidemiology of Lassa Fever within West Africa , 2020, Biology.

[12]  C. Picard,et al.  Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus , 2020, Emerging microbes & infections.

[13]  S. Günther,et al.  Lassa Fever: Epidemiology, Clinical Features, Diagnosis, Management and Prevention. , 2019, Infectious disease clinics of North America.

[14]  Mosoka P. Fallah,et al.  Lassa virus circulating in Liberia: a retrospective genomic characterisation. , 2019, The Lancet. Infectious diseases.

[15]  R. Peeling,et al.  Sensitivity and specificity of diagnostic tests for Lassa fever: a systematic review , 2019, BMC Infectious Diseases.

[16]  E. Musa,et al.  Increase in Lassa Fever Cases in Nigeria, January–March 2018 , 2019, Emerging infectious diseases.

[17]  V. Oti A Reemerging Lassa Virus: Aspects of Its Structure, Replication, Pathogenicity and Diagnosis , 2018, Current Topics in Tropical Emerging Diseases and Travel Medicine.

[18]  Catherine A. Freije,et al.  Genomic analysis of Lassa virus from the 2018 surge in Nigeria , 2018, The New England journal of medicine.

[19]  S. Hallam,et al.  Review of Mammarenavirus Biology and Replication , 2018, Front. Microbiol..

[20]  E. Saphire,et al.  Lassa virus glycoprotein: stopping a moving target , 2018, Current Opinion in Virology.

[21]  M. Suchard,et al.  Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7 , 2018, Systematic biology.

[22]  A. Maxmen Deadly Lassa-fever outbreak tests Nigeria's revamped health agency , 2018, Nature.

[23]  Daniel L. Ayres,et al.  Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10 , 2018, Virus evolution.

[24]  N. Forrester,et al.  Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage , 2015, Front. Microbiol..

[25]  Elizabeth M. Ryan,et al.  Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus , 2015, Cell.

[26]  Giovanni Lo Iacono,et al.  Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever , 2015, PLoS neglected tropical diseases.

[27]  A. Peterson,et al.  Mapping Transmission Risk of Lassa Fever in West Africa: The Importance of Quality Control, Sampling Bias, and Error Weighting , 2014, PloS one.

[28]  J. T. ter Meulen,et al.  The Impact of Human Conflict on the Genetics of Mastomys natalensis and Lassa Virus in West Africa , 2012, PloS one.

[29]  S. Günther,et al.  Current Molecular Epidemiology of Lassa Virus in Nigeria , 2010, Journal of Clinical Microbiology.

[30]  C. Roth,et al.  New opportunities for field research on the pathogenesis and treatment of Lassa fever. , 2008, Antiviral research.

[31]  Alan Y. Chiang,et al.  Generalized Additive Models: An Introduction With R , 2007, Technometrics.

[32]  S. Günther,et al.  Mastomys natalensis and Lassa Fever, West Africa , 2006, Emerging infectious diseases.

[33]  M. Galan,et al.  Molecular identification of four cryptic species of Mastomys (Rodentia, Murinae) , 2005 .

[34]  S. Günther,et al.  Lassa Virus , 2004, Critical reviews in clinical laboratory sciences.

[35]  E. S. Smith,et al.  A prospective study of the epidemiology and ecology of Lassa fever. , 1987, The Journal of infectious diseases.

[36]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[37]  Hadley Wickham,et al.  ggmap: Spatial Visualization with ggplot2 , 2013, R J..

[38]  T. Monath,et al.  Recent isolations of Lassa virus from Nigerian rodents. , 1975, Bulletin of the World Health Organization.